Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients
NCT04933435 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78
Last updated 2025-11-19
Summary
This is a research study to evaluate change in Quality of Life, as defined by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC C-30), from baseline to 1 month post treatment in two patient cohorts receiving Interventional Radiology Liver Directed Therapies or Hypofractionated Image-Guided Radiation Therapy.
Conditions
Interventions
- OTHER
-
Quality of life questionnaires
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (QLQ-C30) and Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep)
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Manisha Palta, MD · Duke Health
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-12
- Primary Completion
- 2027-02-28
- Completion
- 2027-02-28
Countries
- United States
Study Locations
More Related Trials
-
Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
NCT06389422 ·Status: RECRUITING ·Phase: PHASE2
-
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
NCT00019604 ·Status: TERMINATED ·Phase: PHASE2
-
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
NCT02626312 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
NCT00557024 ·Status: UNKNOWN ·Phase: PHASE4
-
Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
NCT00132041 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation
NCT01340105 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma
NCT01643824 ·Status: COMPLETED ·Phase: NA
-
MRI-guided Holmium-166 Radioembolization
NCT05609448 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma
NCT02395523 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant
NCT01194206 ·Status: WITHDRAWN ·Phase: PHASE2
-
Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery
NCT00956930 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
NCT01668134 ·Status: COMPLETED ·Phase: PHASE1
-
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
NCT01850667 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Antiviral Therapy on Patients With HBV-related HCC
NCT05406089 ·Status: COMPLETED
-
Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer
NCT01126645 ·Status: COMPLETED ·Phase: PHASE2
-
Transarterial Chemoembolization Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
NCT02470533 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC)
NCT01801163 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC
NCT04124991 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma
NCT05031949 ·Status: RECRUITING ·Phase: PHASE1
-
Ablation Combined With PD-1 in HCC: Phase II Study
NCT04652440 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma
NCT04299581 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
NCT00230347 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver
NCT02966223 ·Status: TERMINATED ·Phase: NA
-
Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC
NCT05433701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver Cancer
NCT05160740 ·Status: RECRUITING ·Phase: NA